Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
SEQUENT
SEQUENT

Viyash Scientific Ltd.

NSE: VIYASH
BSE: 512529
Sector: Healthcare
Industry: Pharmaceuticals
204.18-3.8 (-1.83%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

84.1 / 100

Value Score

23.5 / 100

Price Momentum Score

63.0 / 100

QVM Score

61.7 / 100

Key Metrics

Market Cap
9011.50
P/E (TTM)
52.65
P/B
3.10
P/S (TTM)
2.86
EV/EBITDA
15.39
CAPE (5Y)
1317.29
ROE (TTM)
9.81
ROCE (TTM)
17.32
ROA (TTM)
5.69
Avg 3Y ROE
2.58
Earnings 3Y CAGR
-
Sales 3Y CAGR
30.62
Sales 5Y CAGR
18.08
Debt/Equity
0.17
Consensus TP
320.00
Strong Buy %
100.00
Promoter Holding
49.24
Pledged %
0.00

Share Price

Track Viyash Scientific Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

204.18-3.8 (-1.83%) D
0.96% in past 1 year
1 Week returns: -9.65 %
Low
197.0
High
229.9
1 Month returns: -19.53 %
Low
197.0
High
253.4
1 Year returns: 0.29 %
Low
178.1
High
298.0
3 Year CAGR: 28.52 %
Low
92.1
High
298.0
5 Year CAGR: 1.57 %
Low
61.8
High
298.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Viyash Scientific Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Company's earnings are of high quality

Earnings quality score of 74.7 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

74.7 / 100

Negative
Expensive and at a premium to industry median P/E

PE TTM of 52.65 indicates that the stock is expensive on a standalone basis and is at a 72.79% premium to industry median P/E

What is P/E Ratio?

Median: 30.47
Value 52.65
-0.82614.73
Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -5.86% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

9.55May 269.92Jun 2610.54Jul 2610.05Aug 2610.37Sep 2610.62Oct 26
Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
No red flags found!
No significant red flags found in the stock.

Financial Snapshot

See detailed analysis

Multi-year trends for Viyash Scientific Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
01k2k3k4k1.4 K CrMar 20231.4 K CrMar 20241.6 K CrMar 20253.4 K CrMar 2026
Profit After Tax FY
-0k-0k-0k00k0k0k0k-121.2 CrMar 2023-35.9 CrMar 202421.9 CrMar 2025177.3 CrMar 2026
ROE FY
-20%-15%-10%-5%0%5%10%-17.4%Mar 2023-5.3%Mar 20243.2%Mar 20259.8%Mar 2026
EBITDA FY
00k0k1k1k40.3 CrMar 202384.8 CrMar 2024167.2 CrMar 2025654.3 CrMar 2026

Viyash Scientific Ltd. Shareholding Pattern

Quarterly breakdown of Viyash Scientific Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Total Promoter
56.15
54.87
54.51
53.86
53.86
53.86
53.52
53.02
53.02
52.79
52.79
52.79
52.79
52.79
52.79
52.79
52.79
52.78
52.76
52.61
52.61
52.61
52.33
61.41
61.31
61.31
49.24
Indian Promoter
56.15
54.87
1.49
0.84
0.84
0.84
0.50
-
-
-
-
-
-
-
-
-
-
52.78
-
-
-
-
-
-
-
-
-
Foreign Promoter
-
-
53.02
53.02
53.02
53.02
53.02
53.02
53.02
52.79
52.79
52.79
52.79
52.79
52.79
52.79
52.79
-
52.76
52.61
52.61
52.61
52.33
61.41
61.31
61.31
49.24
Institutions
12.55
11.63
13.12
14.84
16.36
16.09
16.15
8.55
7.88
8.72
9.36
9.06
8.82
9.18
9.26
13.34
13.75
13.76
16.44
18.10
18.86
19.14
18.82
10.52
10.93
8.25
10.90
Mutual Funds / UTI
3.79
4.06
4.64
4.51
2.68
2.10
1.49
0.51
0.30
0.29
0.45
0.25
0.25
0.25
1.03
5.02
5.16
5.69
7.41
9.58
10.22
10.08
10.04
5.82
6.44
2.93
7.13
FI/Bank/Insurance
0.21
0.05
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.22
1.21
1.21
0.75
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
8.55
7.49
8.37
10.20
13.15
13.60
14.12
6.42
5.84
6.45
6.57
6.25
5.89
6.27
6.03
6.11
6.16
5.69
6.45
6.10
6.05
6.15
5.90
3.16
2.94
4.50
2.60
Other Institutions
0.00
0.02
0.10
0.14
0.53
0.38
0.55
1.62
1.73
1.97
1.12
1.35
1.46
1.92
2.20
2.21
2.43
2.37
2.58
2.42
2.59
2.90
2.87
1.54
1.54
0.83
1.17
Non-Institution
31.30
33.51
32.37
31.30
29.77
30.06
30.33
38.43
39.11
38.49
37.86
38.15
38.39
38.03
37.96
33.86
33.46
33.46
30.80
29.29
28.53
28.26
28.85
28.06
27.76
30.43
39.86
Bodies Corporate
11.28
13.99
10.31
9.51
6.92
6.67
7.17
8.39
7.86
7.23
7.03
6.85
6.57
6.48
5.92
6.32
6.50
5.94
4.20
2.92
2.67
3.36
3.39
2.51
3.28
4.55
6.15
Others (incl. Retail)
No. of shareholders
20.02
15,520
19.52
18,623
22.06
37,187
21.79
46,014
22.85
61,649
23.39
86,096
23.16
1,23,115
30.04
1,66,711
31.25
1,89,918
31.26
1,95,973
30.83
1,92,771
31.30
1,95,133
31.82
1,90,851
31.55
1,86,479
32.04
1,83,613
27.54
1,72,002
26.96
1,65,770
27.52
1,62,897
26.60
1,53,681
26.37
1,61,574
25.86
1,57,181
24.90
1,46,435
25.46
1,43,177
25.55
1,33,391
24.48
1,26,698
25.88
1,27,546
33.71
1,41,646

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence
#IndexWeightRank
1Nifty Microcap 2500.42%79 / 250
2Nifty Total Market0.02%539 / 746

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Viyash Scientific Ltd. shares as reported to NSE and BSE.

NameMonthTransactionHolding % pre transactionAverage priceQty.Transaction value
Sequent Scientific Employee Stock Plan Trust
Other
December-2023
Market Sale (Disposal)
26th Dec 2023
0.38 %₹ 115.125.50 lac₹ 6.33 cr
Manish Gupta
Director
April-2022
Market Sale (Disposal)
4th Apr 2022
0.26 %₹ 133.952.91 lac₹ 3.90 cr
Manish Gupta
Director
April-2022
Market Sale (Disposal)
4th Apr 2022
0.14 %₹ 138.441.03 lac₹ 1.43 cr
Manish Gupta
Director
April-2022
Market Sale (Disposal)
4th Apr 2022
0.09 %₹ 136.4852.63 k₹ 71.83 lac
Manish Gupta
Director
April-2022
Market Sale (Disposal)
4th Apr 2022
0.29 %₹ 130.1298.03 k₹ 1.28 cr
Manish Gupta
Director
March-2022
Market Sale (Disposal)
25th Mar 2022
0.46 %₹ 133.033.00 lac₹ 3.99 cr
Manish Gupta
Director
March-2022
Market Sale (Disposal)
25th Mar 2022
0.60 %₹ 124.1666.42 k₹ 82.47 lac
Manish Gupta
Director
March-2022
Market Sale (Disposal)
25th Mar 2022
0.57 %₹ 124.122.87 lac₹ 3.56 cr
Manish Gupta
Director
March-2022
Market Sale (Disposal)
11th Mar 2022
0.62 %₹ 125.2054.23 k₹ 67.90 lac
Manish Gupta
Director
March-2022
Market Sale (Disposal)
11th Mar 2022
0.62 %₹ 124.086.32 k₹ 7.84 lac
…

Corporate Actions

History of Viyash Scientific Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Dividend₹ 0.50/share
    Record date: 10th Sep 2021Ex-date: 8th Sep 2021
    Announced on: 30th Jun 2021
  2. Dividend₹ 0.20/share
    Record date: 22nd Aug 2019Ex-date: 21st Aug 2019
    Announced on: 14th May 2019
  3. Others
    Ex-date: 6th Apr 2018Announced on: 26th Mar 2018
    Demerger of the Human API Business into Solara Active Pharma sciences limited.
  4. Dividend₹ 0.20/share
    Record date: 21st Nov 2017Ex-date: 20th Nov 2017
    Announced on: 9th Nov 2017
  5. Stock Split1 : 5
    Ex-date: 25th Feb 2016Announced on: 29th Oct 2015
    Nominal value change from INR 10 to INR 2.

Company Profile

Overview of Viyash Scientific Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has...
Key personnel
Mr. Ramakant Singani
Chief Financial Officer
Ms. Yoshita Susmit Vora
Company Secretary, Compliance Officer
Mr. Prasad Lad
Vice President - Human Resources and Admin
Mr. Nrusimha Srinivasa Rao Bondalapati
Vice President - Quality & Regulatory
Mr. Pankaj Lohan
Vice President, Head - India Formulations
Mr. Attanti Veera Venkata Srinivasa Rao
Vice President - Research & Development (API)
Mr. Alexis Goux
Head - Global Formulations
Mr. Peddanna Gumudavelli
Chief Operating Officer - Appco Pharma LLC, US
View all
Incorporated on
28 Jun 1985
Last Annual
31 Mar 2026
Last Interim
30 Jun 2026
No. of Employees
2,900
IPO date
10 Mar 2016
Free Float
19,59,70,864
Phone no.
+912268534777
Address
3rd Floor, Srivallis Corporate, Plot No. 290, SYN 33 34 PTO 39, Guttala Begumpet, Jubilee Hills,Shaikpet, HYDERABAD, 500033, India

Frequently Asked Questions

What is the current share price of Viyash Scientific Ltd.?
The current share price of Viyash Scientific Ltd. is ₹ 204.18 as of 23 Oct 2026.
What is the market capitalisation of Viyash Scientific Ltd.?
The market capitalisation of Viyash Scientific Ltd. stands at ₹ 9,011.50 Cr.
What is the PE ratio of Viyash Scientific Ltd.?
The Price-to-Earnings (PE) ratio of Viyash Scientific Ltd. is 52.65 as of the latest trailing twelve months data.
What is the ROE and ROCE of Viyash Scientific Ltd.?
Viyash Scientific Ltd. has a Return on Equity (ROE) of 9.81% and a Return on Capital Employed (ROCE) of 17.32% as per the latest financial reports.
What is the 52-week high and low of Viyash Scientific Ltd.?
The 52-week high of Viyash Scientific Ltd. is - and the 52-week low is -.
What is the dividend yield of Viyash Scientific Ltd.?
The dividend yield of Viyash Scientific Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Viyash Scientific Ltd.?
Foreign Institutional Investors (FII) hold 2.60%, Domestic Institutional Investors (DII) hold 7.13% and retail/public investors hold 33.71% of Viyash Scientific Ltd. shares.
What sector does Viyash Scientific Ltd. belong to?
Viyash Scientific Ltd. operates in the Healthcare sector. 100% of analysts have a Buy or Strong Buy rating on Viyash Scientific Ltd. with a consensus target price of ₹ 320.00, implying 56.72% upside from current levels.
What is the beta of Viyash Scientific Ltd.?
The beta of Viyash Scientific Ltd. is 1.25, indicating its price volatility relative to the broader market. Over the past 1 year, Viyash Scientific Ltd. has delivered an absolute return of -4.26%.
What is the RSI of Viyash Scientific Ltd.?
The 14-day Relative Strength Index (RSI) of Viyash Scientific Ltd. is 22.13, placing it in the oversold zone. An RSI above 70 is considered overbought and below 30 is considered oversold.